GlassScriptPhysician profile
Michelle Jones
NPI 1366990442
$46,370.99
in general payments reported to CMS, 2019-2025
31 companies · $832 in 2025
The $832 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $837 · 2022: $1,048 · 2023: $33K · 2024: $11K · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Food and Beverage: $3,228 · Travel and Lodging: $1,738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,520.00 |
| Food and Beverage | $3,228.34 |
| Travel and Lodging | $1,738.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $41,736.28 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $1,347.57 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,148.45 | 2021-2025 | Lifevest |
| Abbott Laboratories | $458.87 | 2021-2025 | Accent, Aveir, Gallant |
| Abiomed | $169.31 | 2022-2024 | |
| Medtronic, INC. | $160.43 | 2024-2025 | Linq II, Corevalve Evolut R |
| Daiichi Sankyo INC. | $143.73 | 2021-2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $121.46 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $113.48 | 2022-2025 | Verquvo |
| Amgen INC. | $105.17 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $104.04 | 2023-2025 | Watchman Flx |
| Penumbra, INC. | $97.41 | 2022 | |
| Pfizer INC. | $89.10 | 2021-2025 | |
| Scpharmaceuticals INC. | $83.77 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $75.91 | 2021-2024 | Farxiga |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $67.40 | 2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $48.30 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $33.97 | 2024 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $31.05 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Organogenesis INC. | $26.27 | 2024 | Puraply Am |
| Edwards Lifesciences Corporation | $24.18 | 2024 | Sapien 3 Ultra Resilia |
| Conmed Corporation | $24.13 | 2025 | Airseal |
| Atricure, INC. | $22.85 | 2024 | |
| Convatec INC. | $22.81 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $19.70 | 2023 | Arcalyst |
| Astellas Pharma US INC | $18.69 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.85 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.79 | 2025 | |
| Amarin Pharma, INC. | $15.67 | 2021 | |
| Altathera Pharmaceuticals LLC | $14.27 | 2025 | Sotalol Hydrochloride |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.